IHS Chemical Week

Regions :: Western Europe :: Switzerland

Syngenta Bidding to Acquire Devgen for €403 Million...

11:00 AM MDT | September 21, 2012 | Natasha Alperowicz

Syngenta announced today that it is bidding to acquire Devgen (Ghent, Belgium), a global leader in hybrid rice and RNA interference (RNAi) technology. Syngenta says that the intended takeover bid is “for all outstanding shares and warrants issued by Devgen, representing a total consideration of around €403 million ($523.4 million).” Devgen is listed on the NYSE Euronext Brussels Exchange and delisting is planned on completion of the transaction. Syngenta has offered €16 for each Devgen share and a price for the warrants set according to...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 




Comments (1) for Syngenta Bidding to Acquire Devgen for €403 Million...
1.
Syngenta desperate attempts to boost up the sales is good ( acquisition of Pasteuria & now for Devgen ) , but investors should be mindful of the facts that syngenta already has so many products in its portfolio for which they have not LIBERATED the potential ( for example - AVICTA , the nematode control product, INVINSA the abiotic stress tolerant product), HYBRID rice germplasm , HIGH OLIEC SUNFLOWER ...VIP cotton , even the products like ABAMECTIN which has great potential has remained in the BACK BURNER , the way in which DUPONT , BAYER liberates the product potential of their AVAUNT, IMIDACLOPRID .. syngenta has largely failed in TMX , EMAMECTIN BENZOATE... I would not be very bullish about the news , syngenta makes about acquisition , unless those acquisitions really pays ... Syngenta acquired FAFRAD ( lawn n garden segment) which they have decided to sell off , of late . company is certainly lacking the EXECUTIONAL LEADERSHIP.
Posted by AJAY GOHIL on Saturday, September 22, 2012 @ 12:08 AM










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa